A comic-book hero is knocking on the door of box-office history. Spider-Man: Brand New Day has been a steady, unstoppable presence in North American theaters, and now it sits just a few million dollars shy of a milestone that has only been reached once before.
After its fifth weekend in release the Tom Holland-led blockbuster closed that frame with roughly $22.2 million, bringing its domestic total to about $891.5 million. Early-week ticket sales then nudged the total higher, and current tallies place the film at approximately $898.1 million in the U.S. market — tantalizingly close to $900 million.
If Brand New Day clears $900 million domestically, it will be only the second film in history to do so.
That lone predecessor is Star Wars: The Force Awakens, which still holds a North American benchmark of $936.7 million. At the moment the gap between the two stands near $38 million, a sizable margin but not an insurmountable one for a picture this hot. Can a Spider-Man movie maintain enough ticket sales in its later weeks to inch past such a long-standing record? It’s a question studios, fans, and box-office trackers are watching closely.

The film’s success isn’t limited to the U.S. Brand New Day has already crossed the $2.3 billion mark worldwide, vaulting into the top tier of the highest-grossing films of all time and overtaking Avatar: The Way of Water to claim the third spot globally. In other words: it’s not just a domestic phenomenon. It’s a global event.
Released in U.S. cinemas on July 31, 2026, the movie’s mix of star power, spectacle, and timing has kept audiences returning. Short legs? Not here. Word of mouth has stretched its run longer than many expected. The late-summer box-office landscape has rarely seen a sequel hold such sway for so many consecutive weeks.
Records are being tested and histories rewritten. Will Brand New Day become the film that finally nudges The Force Awakens off its domestic perch? Keep your eyes on the box-office charts — this race is far from over.




Leave a Comment
Comments
No comments yet. Be the first.